Scientific Business Development Associate, TOS
Boost your chances before you apply.
Champions Oncology Inc.
SC
Summary
The associate acts as a bridge between business development and scientific operations by preparing quotes, proposals, and study designs. They also conduct lead generation and maintain account information within the CRM system to support regional business growth.
Job Description
Job Details: Level: Entry, Job Location: Italy - TBD, NJ, Position Type: Full Time, Education Level: PhD, Salary Range: Undisclosed, Travel Percentage: 0-10 %, Job Shift: Monday - Friday, 9:00 AM - 5:30 PM, Job Category: Sales, POSITION TITLE: Scientific Business Development Associate, Translational Oncology Solutions
REPORTING LOCATION: Remote (Italy preferred)
REPORTS TO (TITLE): Executive Director, Head of Europe and Asia
PRIMARY OBJECTIVE:
The Scientific Business Development Associate serves as an interface between the Business Development team and Champions Oncology’s scientific and operational functions across Europe and Asia.
The role supports the advancement of business opportunities by combining scientific understanding with strong organizational and operational execution. The Associate brings together the information required for model selection, study development, quoting, and proposal preparation while also supporting targeted lead generation and broader Business Development activities.
DUTIES, RESPONSIBILITIES AND PRODUCTIVITY EXPECTATIONS:
Prepares quotes, proposals, and Statements of Work by translating client requirements and internal scientific, operational, and commercial input into accurate study documents.
Supports model selection and the development of preclinical and translational study designs using Champions Oncology’s databases and scientific resources.
Consolidates model information, scientific data, feasibility assessments, timelines, pricing, and other materials required to advance business opportunities.
Works closely with Medical Affairs, R&D, laboratory teams, Project Management, and Operations to address technical questions and obtain required input.
Prepares scientific summaries, datasets, presentations, and materials for internal and client-facing use.
Supports client meeting preparation and participates in scientific or project-specific discussions as required.
Conducts scientifically tailored lead generation and pipeline research across Europe and Asia.
Identifies and qualifies prospective biotechnology and pharmaceutical clients and refers opportunities to the responsible Business Development lead.
Supports account research, conference preparation, and follow-up activities.
Maintains accurate account, activity, and opportunity information within the company’s CRM system.
Supports pipeline reviews, reporting, forecasting, and the improvement of internal Business Development resources and processes.
Performs other duties as assigned.
Qualifications: KNOWLEDGE, SKILLS, AND ABILITIES:
Strong scientific foundation in oncology, cancer biology, molecular biology, immunology, pharmacology, genetics, or a related discipline.
Understanding of oncology drug discovery and the preclinical and translational drug development process.
Understanding of how in vivo, ex vivo, biomarker, and other translational research platforms are used to advance therapeutic programs.
Ability to understand complex scientific requests and translate them into structured study concepts and clear commercial materials.
Excellent verbal, written, and scientific communication skills.
Strong analytical, organizational, and problem-solving abilities with attention to detail.
Ability to manage multiple opportunities and workstreams while proactively following up with internal stakeholders.
Ability to work independently and collaborate effectively across functions, geographies, and time zones.
Professional fluency in English is required. Additional European or Asian language skills are an advantage.
EDUCATION AND EXPERIENCE:
Advanced degree in Cancer Biology, Molecular Biology, Immunology, Pharmacology, Biochemistry, Genetics, or a related biomedical or life sciences discipline.
PhD or equivalent scientific training is preferred.
Relevant experience in academic research, biotechnology, pharmaceutical drug development, a CRO, or another preclinical or translational research environment.
Experience with preclinical oncology models, in vivo or ex vivo pharmacology, immuno-oncology, biomarkers, or translational research is preferred.
Experience supporting multidisciplinary scientific projects or preparing complex scientific or commercial materials is an advantage.
Previous business development, project management, technical sales, or customer-facing experience is beneficial but is not required.
PHYSICAL DEMANDS AND WORK ENVIRONMENT:
Must be able to sit for extended periods and use a computer in a typical remote office environment. Occasional travel may be required.
This description reflects management’s assignment of essential functions, it does not proscribe or restrict the tasks that may be assigned. We celebrate diversity and are committed to creating an inclusive environment for all employees.
Champions Oncology, Inc. provides an end-to-end range of research and development solutions and services that improve the productivity of oncology drug development. Using both in vitro to in vivo testing platforms companies can leverage the expertise at Champions Oncology to help guide decision making for clinical development scenarios.
From screens using commercially-available and custom cell lines, to studies leveraging syngeneic or traditional patient-derived studies xenograft (PDX) models, and modeling treatment response in the clinic, Champions Oncology is your partner in meeting today’s needs and innovating for tomorrow’s challenges.
At the core of our services is the Champions TumorGraft® (CTG) platform, a comprehensive, unique compendium of PDX models that preserve the biological characteristics of human tumors and are highly predictive of clinical outcomes. Services utilizing Champions TumorGrafts® PDX tumor models include evaluating tumor sensitivity/resistance to various single, combination, standard and novel chemotherapy agents, biomarker discovery and the identification of novel drug combinations.
Champions TumorGraft® PDX models are procured through agreements our Clinical Collaboration Network, a series of renowned oncology institutions in the US and around the world, as well as through the company’s Personalized Oncology Solutions business.
Personalized Oncology Solutions assist clinical oncologists by establishing and administering expert tumor panels for their patients to analyze medical records and test results, to assist in understanding conventional and experimental options and to identify and arrange for testing, analysis and study of the patients’ cancer tissues, as appropriate. Additionally, the company offers personalized PDX development, drug studies and genome sequencing, whereby physicians evaluate the effects of cancer drugs and understand the genetic makeup of each patient’s tumor, enabling them to better select treatment regimens.
Founded
2007
Company size
201-500 employees
Industry
Biotechnology
Org type
Public Company
Headquarters
Hackensack, New Jersey
Champions Oncology, Inc. provides an end-to-end range of research and development solutions and services that improve the productivity of oncology drug development. Using both in vitro to in vivo testing platforms companies can leverage the expertise at Champions Oncology to help guide decision making for clinical development scenarios.
From screens using commercially-available and custom cell lines, to studies leveraging syngeneic or traditional patient-derived studies xenograft (PDX) models, and modeling treatment response in the clinic, Champions Oncology is your partner in meeting today’s needs and innovating for tomorrow’s challenges.
At the core of our services is the Champions TumorGraft® (CTG) platform, a comprehensive, unique compendium of PDX models that preserve the biological characteristics of human tumors and are highly predictive of clinical outcomes. Services utilizing Champions TumorGrafts® PDX tumor models include evaluating tumor sensitivity/resistance to various single, combination, standard and novel chemotherapy agents, biomarker discovery and the identification of novel drug combinations.
Champions TumorGraft® PDX models are procured through agreements our Clinical Collaboration Network, a series of renowned oncology institutions in the US and around the world, as well as through the company’s Personalized Oncology Solutions business.
Personalized Oncology Solutions assist clinical oncologists by establishing and administering expert tumor panels for their patients to analyze medical records and test results, to assist in understanding conventional and experimental options and to identify and arrange for testing, analysis and study of the patients’ cancer tissues, as appropriate. Additionally, the company offers personalized PDX development, drug studies and genome sequencing, whereby physicians evaluate the effects of cancer drugs and understand the genetic makeup of each patient’s tumor, enabling them to better select treatment regimens.
Founded
2007
Company size
201-500 employees
Industry
Biotechnology
Org type
Public Company
Headquarters
Hackensack, New Jersey